Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 28;11(2):39-42.
doi: 10.1002/cld.669. eCollection 2018 Feb.

Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use

Maham Lodhi  1 , Jaimin Amin  1 , Sheila Eswaran  1
Affiliations
Review

Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use

Maham Lodhi et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathogenesis of NASH. Abbreviations: IL, interleukin; TNF, tumor necrosis factor.
Figure 2
Figure 2
(A) Effects of alcohol J‐shaped curve. (B) Variable convexity of J‐shaped curve. Abbreviations: GI, gastrointestinal; T2DM, type 2 diabetes mellitus. (A) Adapted with permission.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non‐alcoholic fatty liver disease. Dig Dis 2010;28:155‐161. - PubMed
    1. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease, meta‐analysis of effects on lipids and haemostatic factor. Br Med J 1999;319:1523‐1528. - PMC - PubMed
    1. James OF, Day CP. Non‐alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998;29:495‐501. - PubMed
    1. Ajmera V, et al. No benefit from modest alcohol use in nonalcoholic fatty liver disease. The Liver Meeting, American Association for the Study of Liver Diseases; November 11‐15, 2016; Boston, MA. Abstract 31.
    1. Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N, et al. Prevalence of nonalcoholic steatohepatitis‐associated cirrhosis in the United States: an analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol 2017;112:581‐587. - PubMed